type2 diabetes
Conditions
Interventions
Pioglitazone 15mg daily
Metformin 750mg daily
Sponsors
Tohoku University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: type 2 diabetes
Exclusion criteria
Exclusion criteria: severe renal dysfunction severe liver dysfunction heart failure history of lactic acidosis severe retinopathy severe vascular disease with urgent treatment HbA1c over 9% blood pressure over 180/100 mmHg
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change of carotid arterial elasticity | — |
Secondary
| Measure | Time frame |
|---|---|
| changes of serum markers of atheroscrerosis,pulse wave velocity and carotid intima-media thickness | — |
Countries
Japan
Contacts
Public ContactYasushi Ishigaki
Tohoku University Graduate School of Medicine Division of Molecular Metabolism and Diabetes
Outcome results
None listed